CBK vs DGX · P/E 11, rev $121.6M vs P/E 22, rev $5.94B
Commercial Bancgroup, Inc. Common Stock (CBK) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Commercial Bancgroup, Inc. Common Stock (CBK) is a banks - regional company listed on NASDAQ.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported CBK revenue for 2025-12-31 was $121.6M. Net income was $37.2M. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. CBK currently screens at market cap $426.5M and trailing P/E 11.2.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CBK currently screens at market cap $426.5M and trailing P/E 11.2. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CBK and DGX stock pages for the full models.
Not investment advice.